BrightSpring Health Services, Inc. (BTSG) Earnings Call Transcripts

BrightSpring Health Services, Inc.'s Latest Earnings Call - June 9, 2026

In the Q2 2026 earnings call for BrightSpring Health Services, the company reported a robust revenue growth trajectory, with expectations for a 15% to 20% growth rate from 2026 to 2028. Revenue growth was driven by strong performance in specialty pharmacy, which has outpaced market growth, and continued wins in limited distribution drugs (LDDs). Management maintained a positive outlook, indicating that the growth from LDDs won in 2024 will significantly contribute to 2026 revenues, while also signaling potential for M&A activity as leverage decreases to around 2.4x.

Reported metrics

Guidance from management

Management maintained a growth outlook of 15% to 20% from 2026 to 2028, supported by strong volume growth and LDD wins, indicating confidence in future performance.

What management said

It's a good question. Obviously, this is an area that we do have some interest potentially in M&A. We're certainly thinking about the buy versus build. As we think -- there's definitely 5 to 10 markets that we laid out -- I don't think we actually laid out the markets, but we talked about 5 to 10 markets that we would be interested in expanding into over the next handful of years, at the Investor Day, in our infusion...

Yes. So as you think about script growth, so what we report externally is obviously just total gross profit per script, because we just have the total pharmacy script. Certainly, depending on how growth rate changes in each of our individual businesses could impact the GP per script, but as -- and that's the mix shift. So if specialty is growing faster than other areas of pharmacy, we've seen that shift up. But wha...

What analysts pressed on

Analysts expressed concerns regarding the impact of regulatory changes from the IRA on home and community pharmacy revenues. There were also inquiries about the integration of services and how the company plans to optimize clinical structures.

Main topics on the call

• Revenue Growth Acceleration — BrightSpring reported a growth rate of 20% in the last few years, significantly above the mid-teens framework previously referenced. CFO Jennifer Phipps stated, "we've seen really good growth across all of our businesses...
• Specialty Pharmacy Performance — The specialty pharmacy business continues to be a core driver, contributing over 75% of EBITDA and growing faster than the overall market. Phipps noted, "our targeted strategy around LDDs has been very helpful in that," ...
• Management Guidance on Future Growth — Management provided a growth algorithm of 15% to 20% from 2026 to 2028, underpinned by strong volume growth and LDD wins. Phipps mentioned, "we have pretty good visibility, again, 12-plus months out from a launch," indic...
• M&A Strategy — The company is exploring M&A opportunities, particularly in the $3 million to $15 million EBITDA range, as leverage decreases. Phipps stated, "we think that there's opportunities for us to leverage really the M&A platfor...

Read the full BrightSpring Health Services, Inc. transcript (June 9, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 21 BrightSpring Health Services, Inc. earnings call transcripts on record, spanning May 2, 2024 to July 31, 2026. Based on this history, BrightSpring Health Services, Inc. reports quarterly. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

BTSG

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

21

First call

May 2, 2024

Most recent

July 31, 2026

Reporting cadence

quarterly